Understanding how ClpXP proteins work in cells
Structure and function of ClpXP
This study is looking at how a special protein called ClpXP helps cells get rid of harmful proteins and keep everything running smoothly, which could be important for understanding health and finding new treatments for diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10812507 on NIH RePORTER |
What this research studies
This research investigates the structure and function of ClpXP, a type of protease that plays a crucial role in removing toxic proteins and regulating essential cellular processes. By examining how ClpXP recognizes and unfolds specific target proteins for degradation, the research aims to uncover the mechanisms that protect cells from unwanted protein degradation. The study focuses on both bacterial and mammalian ClpXP, exploring its implications in health and disease, including its potential as an antibiotic target.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by diseases related to protein misfolding or degradation, such as certain bacterial infections or mitochondrial disorders.
Not a fit: Patients with conditions unrelated to protein degradation mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases caused by dysfunctional protein degradation, including potential antibiotic therapies.
How similar studies have performed: Previous research has shown success in understanding similar protease mechanisms, indicating a strong foundation for this investigation.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Sauer, Robert T — Massachusetts Institute of Technology
- Study coordinator: Sauer, Robert T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.